This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Daiichi Sankyo Company, Limited, National Cancer Center. Active years: 2018.
Company Filing History:
1 out of 460 
1 out of 263 
Years Active: 2018
Title: Yohei Kiyotsuka: Innovator in Cancer Research
Introduction
Yohei Kiyotsuka is a prominent inventor based in Shinagawa-ku, Japan. He has made significant contributions to the field of cancer research, particularly through his innovative work on isoxazole derivatives.
Latest Patents
Kiyotsuka holds a patent for an isoxazole derivative as a mutant isocitrate dehydrogenase 1 inhibitor. This compound, characterized by its isoxazole skeleton, exhibits excellent inhibitory activity against the mutant IDH1 protein. It effectively inhibits the production of 2-HG by this protein and has shown the capability to inhibit the growth of various tumors expressing the protein. The specific details of the compound are defined in the patent claims.
Career Highlights
Throughout his career, Kiyotsuka has worked with notable organizations, including Daiichi Sankyo Company, Limited and the National Cancer Center. His work has been instrumental in advancing cancer treatment options.
Collaborations
Kiyotsuka has collaborated with various professionals in his field, including his coworker Masao Itoh.
Conclusion
Yohei Kiyotsuka's innovative contributions to cancer research through his patent on isoxazole derivatives highlight his role as a key figure in the fight against cancer. His work continues to inspire advancements in medical science.